Sign inJoin waitlistJoin the waitlist

MK

Metin Kurtoglu

Credentials: · · ·

History

Hematology and Medical Oncology
Clinical Center at the National Institutes of Health
2012–2015
Internal Medicine
2011–2014
Doctor of Medicine
2007–2011

Research

A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors
Cancer Chemotherapy and Pharmacology · 2013 · 465 citations
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase…
The Lancet Neurology · 2023 · 236 citations
Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation
Molecular Cancer Therapeutics · 2007 · First of 9 authors · 213 citations

James Howard
4 papers
MK
Murat Kalayoglu
4 papers
Niramol Savaraj
4 papers
TM
Tahseen Mozaffar
4 papers
Tuan Vu
4 papers
Gregory Sahagian
3 papers
MF
Marc Feinberg
3 papers
Volkan Granit
3 papers
Ahmed Chaudhary
2 papers
HL
Howard Leung
2 papers · 1 as a resident
Jaime Merchan
2 papers
NC
Nizar Chahin
2 papers

Clinical trials

Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma
Study director · Terminated · Phase 1
Cartesian Therapeutics
2018–2021